- Home
- USA vs SLNO Comparison
USA vs SLNO Comparison
Compare USA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USA
- SLNO
- Stock Information
- Founded
- USA 1986
- SLNO 1999
- Country
- USA United States
- SLNO United States
- Employees
- USA N/A
- SLNO N/A
- Industry
- USA Finance Companies
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- USA Finance
- SLNO Health Care
- Exchange
- USA Nasdaq
- SLNO Nasdaq
- Market Cap
- USA N/A
- SLNO 3.8B
- IPO Year
- USA N/A
- SLNO 2014
- Fundamental
- Price
- USA $6.87
- SLNO $82.76
- Analyst Decision
- USA
- SLNO Strong Buy
- Analyst Count
- USA 0
- SLNO 9
- Target Price
- USA N/A
- SLNO $105.11
- AVG Volume (30 Days)
- USA 880.5K
- SLNO 1.5M
- Earning Date
- USA 01-01-0001
- SLNO 08-06-2025
- Dividend Yield
- USA 9.66%
- SLNO N/A
- EPS Growth
- USA N/A
- SLNO N/A
- EPS
- USA N/A
- SLNO N/A
- Revenue
- USA N/A
- SLNO N/A
- Revenue This Year
- USA N/A
- SLNO N/A
- Revenue Next Year
- USA N/A
- SLNO N/A
- P/E Ratio
- USA N/A
- SLNO N/A
- Revenue Growth
- USA N/A
- SLNO N/A
- 52 Week Low
- USA $5.62
- SLNO $41.50
- 52 Week High
- USA $7.09
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- USA 59.95
- SLNO 52.50
- Support Level
- USA $6.84
- SLNO $79.70
- Resistance Level
- USA $6.94
- SLNO $90.32
- Average True Range (ATR)
- USA 0.06
- SLNO 3.63
- MACD
- USA 0.01
- SLNO -0.52
- Stochastic Oscillator
- USA 74.24
- SLNO 28.81
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.